Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 11Thoracic 8Dermatologic 7Other hematologic neoplasm 4Genitourinary 4Tumor-Agnostic 3Lymphoid 3Other 2Myeloid 2Breast 2Plasma cell 1Other solid neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Melanoma 2Carcinoma, Renal Cell 2Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Neoplasm Metastasis 1Kidney Neoplasms 1Diarrhea 1Colitis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Docetaxel 390pembrolizumab 326Prednisone 285Gemcitabine 273enzalutamide 256Radiotherapy 251Nivolumab 248Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 198Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 99abiraterone 99cabozantinib 98atezolizumab 97Sorafenib 97Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Fecal Microbiota Transplantation × Genitourinary × Clear all
NCT06206707 2025-11-17

Immunobiome

University of Aarhus

Phase NA Recruiting
20 enrolled
DermatologicGenitourinary

Colitis, Diarrhea, Kidney Neoplasms, Melanoma

NCT04163289 2025-09-15

PERFORM

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 1 Active not recruiting
20 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT05286294 2025-07-03

MITRIC

Oslo University Hospital

Phase 2 Active not recruiting
20 enrolled
DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT04116775 2022-06-23

Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.

Portland VA Medical Center

Phase 2 Unknown
32 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡